🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Florid › Orlando

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Orlando, FL

7 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #48, Celebration · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • AdventHealth Orlando, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • Clermont Oncology Center, Clermont · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Ap rekriteFaz 1
  • Orlando Health, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT07484022

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Ap rekriteFaz 1
  • Dren Investigational Site, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.